Steris | STE - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
3M USD 2.96B 774M 2026-06
Accuray USD 41.29M 22.05M 2025-12
Baxter International USD 2.15B 133M 2026-06
Becton, Dickinson and Co. USD 708M 105M 2026-06
Boston Scientific USD 539M 914M 2026-06
CONMED USD 35.03M 5.79M 2026-03
Cooper Companies USD 138.8M 13.9M 2026-03
Dexcom USD 1.1B 13.2M 2026-06
Ecolab USD 5.14B 4.62B 2026-06
Edwards Lifesciences USD 2.9B 500M 2026-06
Fortive USD 374.2M 18.1M 2026-06
Getinge SEK 2.05B 909M 2026-06
Globus Medical USD 507.74M 53.2M 2026-06
Haemonetics USD 223.38M 22.06M 2026-06
Idexx Laboratories USD 196.93M 3.6M 2026-06
Inogen USD 106.48M 2.79M 2025-09
Insulet USD 534.9M 54.5M 2026-06
Integra LifeSciences USD 214.42M 22.39M 2026-06
Intuitive Surgical USD 8.63B 646.3M 2026-06
J&J USD 20.42B 1.27B 2026-06
Olympus JPY 147.24B 93.98B 2025-09
Orthofix International USD 103.81M 16.47M 2026-06
Owens Minor USD 7.65M 329.23M 2026-06
ResMed USD 1.47B 191.28M 2026-06
Steris USD 482.3M 42.7M 2026-06
Stryker USD 3.39B 513M 2026-06
Tandem Diabetes Care USD 62.82M 116.51M 2026-06
Teleflex USD 300.16M 9.25M 2026-06
Thermo Fisher Scientific USD 3.25B 6.6B 2026-03
Zimmer Biomet Holdings USD 410M 14.2M 2026-06